Journal of Radiation Protection and Research

The Korean Association for Radiation Protection (대한방사선방어학회)
권호 표지

Bladder Volume Variations in Patients Receiving Conformal Radiotherapy to Prostate

전립선암 환자의 방사선 치료 시 방광 체적 변화

  • Lee, Re-Na (Department of Radiation Oncology, School of Medicine, Ewha Womans University) ;
  • Lee, Ji-Hye (Department of Radiation Oncology, School of Medicine, Ewha Womans University) ;
  • Lee, Kyung-Ja (Department of Radiation Oncology, School of Medicine, Ewha Womans University) ;
  • Ji, Young-Hoon (Laboratory of Radiation Medical Physics, Korea Institute of Radiological and Medical Sciences)
  • 이레나 (이화여자대학교 의학전문대학원 방사선종양학과) ;
  • 이지혜 (이화여자대학교 의학전문대학원 방사선종양학과) ;
  • 이경자 (이화여자대학교 의학전문대학원 방사선종양학과) ;
  • 지영훈 (원자력의학원 방사선 의학물리 연구팀)
  • Published : 2008.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objective: To reduce urinary side effects in prostate cancer patients receiving radiation, patients were asked to drink certain amount of water to maintain bladder volume constant and the bladder volumes were measured weekly using ultrasound scanner. Materials and Methods: Twenty-six patients with prostate cancer who received radiation between December 2002 and August 2007 were enrolled in this study. Thirteen patients were enrolled in experimental group. These patients were asked to drink 450 cc of water, one hour prior to simulation, CT scan, and treatment. The other thirteen patients were given no information about bladder filing. Bladder, prostate, and rectum were contoured on CT and volumes were calculated. 3D conformal treatment planning was performed and effective volumes of bladder were calculated when a prescription dose of 70.2 Gy was delivered. For the patients in experimental group, bladder volumes were measured weekly using ultrasound scanner for 6-8 weeks and the bladder volume variations were analyzed. Results: Average bladder volumes and standard deviations obtained at CT scanning were $283.5{\pm}114.0\;cc$ (40%) and $181.2{\pm}120.1\;cc$ (66%) in experimental and control groups, respectively. Although it was not statistically significant, there was correlation between the bladder volumes measured from CT and ultrasound. The volumes measured using ultrasound scanner were 62% lower than the volumes using CT images on average. There was significant variations in volumes measured weekly for 6-8 weeks. It ranged between 33 - 75 %. Conclusion: Our results showed that it is possible to obtain larger bladder volume if they are asked to drink certain amount of water prior to CT scan. However, patients were unable to maintain constant bladder volumes over the 6-8 weeks of treatment period although they were asked to drink constant amount of water.

목 적: 전립선암 환자의 방사선 치료 시 전립선의 위치 변화 및 비뇨기계 부작용을 줄이기 위해 방광의 체적을 일정하게 유지하도록 한 후 초음파를 이용하여 방광의 체적 변화를 측정 하였다. 대상 및 방법: 2002년 12월부터 2007년 8월 까지 이대 목동병원에서 전립선 암으로 진단받고 근치적 목적의 방사선 치료를 받은 환자 26명을 대상으로 하였다. 13명의 실험군 환자는 방광의 체적을 일정하게 유지하기 위하여 모의조사, CT 스캔, 및 치료 1시간 전에 450 cc의 물을 마시도록 하였다. 나머지 13명의 대조군 환자에 대해서는 특별한 지시를 하지 않았다. 각 환자의 CT영상에서 방광의 체적을 측정하였다. 3차원 입체 조형 치료 계획이 설계되었고 처방선량 70.2 Gy 조사할 경우 방광과 직장의 유효체적을 계산 하였다. 실험군에 속해 있는 환자에 대해 방사선 치료 전 방광의 체적을 초음파를 이용하여 6-8주 간 매주 측정하였고 방광의 체적 변화를 분석하였다. 결과: CT상에서 측정 한 방광의 평균 체적 및 표준 오차는 실험군의 경우 $283.5{\pm}114.0\;cc$ (40%) 이고 대조군의 경우 $181.2{\pm}120.1\;cc$ (66%) 이다. 실험군의 경우 CT 상의 방광 체적과 CT scan 전에 획득한 초음파 영상상의 방광 체적은 통계적으로 유의하지 않으나 상관관계가 있는 것으로 보이고 초음파를 이용하여 측정한 방광의 체적은 CT상에서의 체적의 평균 62% 이다. 실험군에 있어서 초음파 시스템을 이용하여 주간 측정한 방광의 체적의 변화는 상당히 컸으며 최소 33%에서 최대 75%까지 변화 하였다. 결론: CT 스캔 전에 일정한 양의 물을 마시도록 지시한 실험군의 환자들의 경우 대조군대비 평균 방광의 체적을 크게 유지할 수 있었다. 그러나 일정한 양의 물을 마시도록 지시하더라도 6-8주간의 치료 기간 중에 방광의 체적을 일정히 유지 하는데는 어려움이 있었다.

Keywords

References

  1. Zelefsky MJ, Leibel SA, Guadin PB, Kutcher GJ, Fleshner NE, Venkatramen ES, Reuter VE, Fair WR, Ling CC, Fuks Zet. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys. 1998;41:491-500 https://doi.org/10.1016/S0360-3016(98)00091-1
  2. Hanks GE, Hanlon AL, Epstein B, Horwitz EM. Dose response in prostate cancer with 8-12 years' follow-up. Int J Radiat Oncol Biol Phys. 2002;54:427-435 https://doi.org/10.1016/S0360-3016(02)02954-1
  3. Pollack A, Zagars GK, Starkschall G, Starkschall G, Antolak JA, Lee JJ, Huang E, von Eschenbach AC, Kuban DA, Rosen I. Prostate cancer radiation dose-response: results of the M.D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys. 2002;53:1097-1105 https://doi.org/10.1016/S0360-3016(02)02829-8
  4. Dearnaley DP, Hall E, Lawrence D, Huddart RA, Eeles R, Nutting CM, Gadd J, Warrington A, Bidmead M, Horwich A. Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects. Int J Radiat Oncol Biol Phys. 2005;92:488-498
  5. Lebesque JV, Bruce AM, Kroes AP, Kroes AO, Touw A, Shouman RT, van Herk M. Variation in volumes, dose volume histograms, and estimated normal tissue complication probabilities of rectum and bladder during conformal radiotherapy of T3 prostate cancer. Int J Radiat Oncol Biol Phys. 1995;33:1109-1119 https://doi.org/10.1016/0360-3016(95)00253-7
  6. Fiorino C, Foppiano F, Franzone P, Broggi S, Castellone P, Marcenaro M, Calandrino R, Sangquineti G. Rectal and bladder motion during conformal radiotherapy after radical prostatectomy. Radiother Oncol. 2005;74:187-195 https://doi.org/10.1016/j.radonc.2004.10.002
  7. Fokdal L, Honore H, Hoyer M, Meldgaard P, Fode K, von der Maase H. Impact of changes in bladder and rectal filling volume on organ motion and dose distribution of the bladder in radiotherapy after urinary bladder cancer. Int J Radiat Oncol Biol Phys. 2004;59:436-444 https://doi.org/10.1016/j.ijrobp.2003.10.039
  8. Emami B, Lyman J, Brown A, Coia L, Goitein M, Munzenrider JE, Shank B, Solin LJ, Wesson M. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys. 1991;21:102-122
  9. Marks LB, Carroll PR, Dugan TC, Anscher MS. The response of the urinary bladder, urethra, and ureter to radiation and chemotherapy. Int J Radiat Oncol Biol Phys. 1995;31:1257-1280 https://doi.org/10.1016/0360-3016(94)00431-J
  10. Mundt AJ, Roeske JC, Lujan AE, Yamada SD, Waggoner SE, Fleming G, Rotmensch J. Initial clinical experience with intensity modulated whole pelvis radiation therapy in women with gynecologic malignancies. Gynecol Oncol. 2001;82:456-465 https://doi.org/10.1006/gyno.2001.6250
  11. Guckenberger M, Meyer J, Wilbert J, Baier K, Bratengeier K, Vordermark D, Flentje M. Precision required for doseescalated treatment of spinal metastases and implications for image-guided radiation therapy (IGRT). Radiother Oncol. 2007;84(1):56-63 https://doi.org/10.1016/j.radonc.2007.05.021
  12. Cui Y, Dy JG, Sharp GC, Alexander B, Jiang SB. Multiple template-based fluoroscopic tracking of lung tumor mass without implanted fiducial markers. Phys Med Biol. 2007: 52(20);6229-6242 https://doi.org/10.1088/0031-9155/52/20/010
  13. Seppenwoolde Y, Berbeco RI, Nishioka S, Shirato H, Heijmen B. Accuracy of tumor motion compensation algorithm from a robotic respiratory tracking system: a simulation study. Med Phys. 2007;34(7):2774-2784 https://doi.org/10.1118/1.2739811
  14. Fokdal L, Honore H, Hoyer M, Meldgaard P, Fode K, von der Maase H. Impact of changes in bladder and rectal filling volume on organ motion and dose distribution of the bladder in radiotherapy for urinary bladder cancer. Int J Radiat Oncol Biol Phys. 2004;59:436-444 https://doi.org/10.1016/j.ijrobp.2003.10.039
  15. Sur RK, Clinkard J, Jones WG, et al. Changes in target volume during radiotherapy treatment of invasive bladder carcinoma. Clin Oncol 1993;5:30-33 https://doi.org/10.1016/S0936-6555(05)80693-4
  16. Harris SJ, Buchanan RB. An audit and evaluation of bladder movements during radical radiotherapy. Clin Oncol. 1998;10:262-264 https://doi.org/10.1016/S0936-6555(98)80014-9
  17. Miralbell R, Nouet P, Rouzaud M, Bardina A, Hejira N, Schneider D. Radiotherapy of bladder cancer: relevance of bladder volume changes in planning boost treatment. Int J Radiat Oncol Biol Phys. 1998;41:741-746 https://doi.org/10.1016/S0360-3016(98)00131-X
  18. Meijer GJ, Rasch C, Remeijer P, Lebesque JV. Threedimensional analysis of delineation errors, setup errors, and organ motion during radiotherapy of bladder cancer. Int J Radiat Oncol Biol Phys. 2003;55:1277-1287 https://doi.org/10.1016/S0360-3016(02)04162-7
  19. Muren LP, Smaaland R, Dahl O. Organ motion, set-up variation and treatment margins in radical radiotherapy of urinary bladder cancer. Radiother Oncol 2003;69:291-304 https://doi.org/10.1016/S0167-8140(03)00246-9
  20. Sur RK, Clinkard J, Jones WG, et al. Changes in target volume during radiotherapy treatment of invasive bladder carcinoma. Clin Oncol 1993;5:30-33 https://doi.org/10.1016/S0936-6555(05)80693-4
  21. Pinkawa M, Asadpour B, Siluschek J, Gael B, Piroth MD, Dimirel C, Eble MJ, Bladder extension variability during pelvic external beam radiotherapy with a full or empty bladder. Radiother Oncol 2007;83:163-167 https://doi.org/10.1016/j.radonc.2007.03.015